10:15 AM EDT, 04/04/2024 (MT Newswires) -- Amy Simon, Chief Medical Officer, on April 01, 2024, sold 23,687 shares in Beam Therapeutics ( BEAM ) for $734,805. Following the Form 4 filing with the SEC, Simon has control over a total of 70,060 shares of the company, with 70,060 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1745999/000095017024041441/xslF345X03/ownership.xml

Price: 29.91, Change: +0.23, Percent Change: +0.76